nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Estradiol—NR1I2—bone cancer	0.0672	0.286	CrCbGaD
Levorphanol—Dihydrocodeine—CYP3A4—bone cancer	0.0403	0.172	CrCbGaD
Levorphanol—Hydrocodone—CYP3A4—bone cancer	0.0309	0.132	CrCbGaD
Levorphanol—Hydromorphone—CYP3A4—bone cancer	0.0256	0.109	CrCbGaD
Levorphanol—Morphine—CYP3A4—bone cancer	0.0218	0.0927	CrCbGaD
Levorphanol—Dextromethorphan—CYP3A4—bone cancer	0.0183	0.0778	CrCbGaD
Levorphanol—Hypoxia—Methotrexate—bone cancer	0.0178	0.0232	CcSEcCtD
Levorphanol—Estrone—CYP3A4—bone cancer	0.0175	0.0747	CrCbGaD
Levorphanol—Cyanosis—Methotrexate—bone cancer	0.0159	0.0208	CcSEcCtD
Levorphanol—Amnesia—Cisplatin—bone cancer	0.0159	0.0208	CcSEcCtD
Levorphanol—Hypokinesia—Epirubicin—bone cancer	0.0156	0.0204	CcSEcCtD
Levorphanol—Hypokinesia—Doxorubicin—bone cancer	0.0145	0.0189	CcSEcCtD
Levorphanol—Apnoea—Methotrexate—bone cancer	0.0133	0.0174	CcSEcCtD
Levorphanol—Estradiol—CYP3A4—bone cancer	0.0133	0.0566	CrCbGaD
Levorphanol—Thinking abnormal—Epirubicin—bone cancer	0.0115	0.0151	CcSEcCtD
Levorphanol—Respiratory failure—Methotrexate—bone cancer	0.0115	0.015	CcSEcCtD
Levorphanol—Renal failure—Cisplatin—bone cancer	0.0113	0.0148	CcSEcCtD
Levorphanol—Dyskinesia—Epirubicin—bone cancer	0.0112	0.0147	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—bone cancer	0.0107	0.0139	CcSEcCtD
Levorphanol—Bradycardia—Cisplatin—bone cancer	0.0105	0.0137	CcSEcCtD
Levorphanol—Injection site reaction—Epirubicin—bone cancer	0.0105	0.0137	CcSEcCtD
Levorphanol—Abnormal dreams—Epirubicin—bone cancer	0.0104	0.0136	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—bone cancer	0.0104	0.0136	CcSEcCtD
Levorphanol—Coma—Methotrexate—bone cancer	0.0103	0.0135	CcSEcCtD
Levorphanol—Visual impairment—Cisplatin—bone cancer	0.00995	0.013	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—bone cancer	0.00971	0.0127	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—bone cancer	0.00965	0.0126	CcSEcCtD
Levorphanol—Coma—Epirubicin—bone cancer	0.00964	0.0126	CcSEcCtD
Levorphanol—Flushing—Cisplatin—bone cancer	0.00958	0.0125	CcSEcCtD
Levorphanol—Arrhythmia—Cisplatin—bone cancer	0.00922	0.0121	CcSEcCtD
Levorphanol—Abnormal vision—Epirubicin—bone cancer	0.00921	0.012	CcSEcCtD
Levorphanol—Mental disability—Epirubicin—bone cancer	0.00916	0.012	CcSEcCtD
Levorphanol—Coma—Doxorubicin—bone cancer	0.00892	0.0117	CcSEcCtD
Levorphanol—Muscle spasms—Cisplatin—bone cancer	0.00864	0.0113	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—bone cancer	0.00852	0.0111	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—bone cancer	0.00847	0.0111	CcSEcCtD
Levorphanol—Lethargy—Methotrexate—bone cancer	0.00835	0.0109	CcSEcCtD
Levorphanol—Lethargy—Epirubicin—bone cancer	0.00782	0.0102	CcSEcCtD
Levorphanol—Convulsion—Cisplatin—bone cancer	0.00778	0.0102	CcSEcCtD
Levorphanol—Mood swings—Methotrexate—bone cancer	0.00776	0.0101	CcSEcCtD
Levorphanol—Diplopia—Epirubicin—bone cancer	0.00766	0.01	CcSEcCtD
Levorphanol—Affect lability—Epirubicin—bone cancer	0.00754	0.00986	CcSEcCtD
Levorphanol—Cardiac arrest—Epirubicin—bone cancer	0.00729	0.00952	CcSEcCtD
Levorphanol—Mood swings—Epirubicin—bone cancer	0.00726	0.00949	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—bone cancer	0.00723	0.00945	CcSEcCtD
Levorphanol—Tachycardia—Cisplatin—bone cancer	0.00716	0.00935	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—bone cancer	0.00709	0.00927	CcSEcCtD
Levorphanol—Hyperhidrosis—Cisplatin—bone cancer	0.00709	0.00926	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—bone cancer	0.00698	0.00912	CcSEcCtD
Levorphanol—Hypotension—Cisplatin—bone cancer	0.00685	0.00896	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—bone cancer	0.00674	0.00881	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—bone cancer	0.00672	0.00878	CcSEcCtD
Levorphanol—Dysuria—Methotrexate—bone cancer	0.00662	0.00865	CcSEcCtD
Levorphanol—Renal failure—Methotrexate—bone cancer	0.0062	0.00811	CcSEcCtD
Levorphanol—Dysuria—Epirubicin—bone cancer	0.00619	0.00809	CcSEcCtD
Levorphanol—Sweating—Methotrexate—bone cancer	0.00605	0.0079	CcSEcCtD
Levorphanol—Feeling abnormal—Cisplatin—bone cancer	0.00604	0.0079	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—bone cancer	0.0058	0.00759	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—bone cancer	0.00573	0.00749	CcSEcCtD
Levorphanol—Sweating—Epirubicin—bone cancer	0.00566	0.0074	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—bone cancer	0.00546	0.00713	CcSEcCtD
Levorphanol—Bradycardia—Epirubicin—bone cancer	0.0054	0.00705	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—bone cancer	0.00537	0.00702	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—bone cancer	0.00524	0.00684	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—bone cancer	0.00511	0.00668	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—bone cancer	0.00499	0.00653	CcSEcCtD
Levorphanol—Flushing—Epirubicin—bone cancer	0.00492	0.00643	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—bone cancer	0.00474	0.00619	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—bone cancer	0.00473	0.00618	CcSEcCtD
Levorphanol—Vomiting—Cisplatin—bone cancer	0.00466	0.00609	CcSEcCtD
Levorphanol—Rash—Cisplatin—bone cancer	0.00462	0.00604	CcSEcCtD
Levorphanol—Dermatitis—Cisplatin—bone cancer	0.00462	0.00604	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—bone cancer	0.00455	0.00595	CcSEcCtD
Levorphanol—Tension—Epirubicin—bone cancer	0.00453	0.00592	CcSEcCtD
Levorphanol—Nervousness—Epirubicin—bone cancer	0.00448	0.00586	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—bone cancer	0.00444	0.0058	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—bone cancer	0.00438	0.00573	CcSEcCtD
Levorphanol—Nausea—Cisplatin—bone cancer	0.00436	0.00569	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—bone cancer	0.00427	0.00558	CcSEcCtD
Levorphanol—Agitation—Epirubicin—bone cancer	0.00424	0.00554	CcSEcCtD
Levorphanol—Tension—Doxorubicin—bone cancer	0.00419	0.00548	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—bone cancer	0.00415	0.00542	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—bone cancer	0.0041	0.00536	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—bone cancer	0.00408	0.00533	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—bone cancer	0.00406	0.0053	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—bone cancer	0.004	0.00522	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—bone cancer	0.00392	0.00513	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—bone cancer	0.00389	0.00508	CcSEcCtD
Levorphanol—Dry mouth—Epirubicin—bone cancer	0.00384	0.00502	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—bone cancer	0.0038	0.00496	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—bone cancer	0.00377	0.00493	CcSEcCtD
Levorphanol—Hypotension—Methotrexate—bone cancer	0.00376	0.00491	CcSEcCtD
Levorphanol—Shock—Epirubicin—bone cancer	0.0037	0.00484	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—bone cancer	0.0037	0.00483	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—bone cancer	0.00368	0.0048	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—bone cancer	0.00364	0.00476	CcSEcCtD
Levorphanol—Insomnia—Methotrexate—bone cancer	0.00364	0.00476	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—bone cancer	0.00355	0.00465	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—bone cancer	0.00354	0.00463	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—bone cancer	0.00352	0.0046	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—bone cancer	0.00351	0.00459	CcSEcCtD
Levorphanol—Shock—Doxorubicin—bone cancer	0.00343	0.00448	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—bone cancer	0.00341	0.00445	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—bone cancer	0.0034	0.00444	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—bone cancer	0.00337	0.0044	CcSEcCtD
Levorphanol—Feeling abnormal—Methotrexate—bone cancer	0.00332	0.00433	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—bone cancer	0.00331	0.00433	CcSEcCtD
Levorphanol—Gastrointestinal pain—Methotrexate—bone cancer	0.00329	0.0043	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—bone cancer	0.00326	0.00426	CcSEcCtD
Levorphanol—Constipation—Epirubicin—bone cancer	0.00322	0.00421	CcSEcCtD
Levorphanol—Urticaria—Methotrexate—bone cancer	0.0032	0.00418	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—bone cancer	0.00318	0.00416	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—bone cancer	0.00315	0.00412	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—bone cancer	0.0031	0.00406	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—bone cancer	0.00308	0.00402	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—bone cancer	0.00307	0.00401	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—bone cancer	0.00299	0.00391	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—bone cancer	0.00298	0.00389	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—bone cancer	0.00298	0.00389	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—bone cancer	0.00287	0.00375	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—bone cancer	0.00285	0.00372	CcSEcCtD
Levorphanol—Pruritus—Methotrexate—bone cancer	0.00285	0.00372	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—bone cancer	0.00277	0.00362	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—bone cancer	0.00275	0.0036	CcSEcCtD
Levorphanol—Pruritus—Epirubicin—bone cancer	0.00266	0.00348	CcSEcCtD
Levorphanol—Dizziness—Methotrexate—bone cancer	0.00266	0.00348	CcSEcCtD
Levorphanol—Vomiting—Methotrexate—bone cancer	0.00256	0.00334	CcSEcCtD
Levorphanol—Rash—Methotrexate—bone cancer	0.00254	0.00332	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—bone cancer	0.00253	0.00331	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—bone cancer	0.00249	0.00325	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—bone cancer	0.00247	0.00322	CcSEcCtD
Levorphanol—Vomiting—Epirubicin—bone cancer	0.00239	0.00313	CcSEcCtD
Levorphanol—Nausea—Methotrexate—bone cancer	0.00239	0.00312	CcSEcCtD
Levorphanol—Rash—Epirubicin—bone cancer	0.00237	0.0031	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—bone cancer	0.00237	0.0031	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—bone cancer	0.0023	0.00301	CcSEcCtD
Levorphanol—Nausea—Epirubicin—bone cancer	0.00224	0.00292	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—bone cancer	0.00222	0.0029	CcSEcCtD
Levorphanol—Rash—Doxorubicin—bone cancer	0.0022	0.00287	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—bone cancer	0.00219	0.00287	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—bone cancer	0.00207	0.0027	CcSEcCtD
